Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
FITUSIRAN
Not marketed
Hemophilia A and B
EFC14769NANCT03417245Tabulated Results
FITUSIRAN
Not marketed
Hemophilia
EFC15110ATLAS-PPXEudraCT: 2016-004087-19Tabulated Results
FLUOROURACIL
Carac
Keratosis
DL6025-0201NANCT00377273Summary
FRESOLIMUMAB
Not marketed
Glomerulosclerosis
DRI12792NAEudraCT: 2012-002365-35Tabulated Results
FRESOLIMUMAB
Not Marketed
Glomerulosclerosis
GC1008FSGS03110NAEudraCT: 2012-002365-35Tabulated Results
FUROSEMIDE
Lasix, Eutensin, Lasilix
Chronic Renal Failure
FUROSL06121NANCT01724788Summary
G-PROTEIN-BIASED S1P1 AGONIST
Not Marketed
Microvascular Coronary Artery Disease
PDY15286NANCT03462017Summary
GEMIGLIPTIN
Zemiglo
Diabetes Mellitus, Type 2
GEMIGL07185NANCT02343926Summary
GIP/GCG/GLP-1 TRIAGONIST
Not Marketed
Obesity
TDU15478NANCT04521738Summary
GLIMEPIRIDE - METFORMIN COMBINATION
Amaryl-M
Diabetes Mellitus, Type 2
EFC11761NANCT01457911Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted